American Green, Inc. (ERBB)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
American Green, Inc. (ERBB) trades at $0.00 with AI Score 39/100 (Grade D). American Green, Inc. operates as a technology firm within the U. S. Market cap: $444,196, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for ERBB: ERBB does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ERBB against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ERBB: 1/1 perspectives are bearish.
How is this calculated? →American Green, Inc. (ERBB) Healthcare & Pipeline Overview
American Green, Inc. is a technology firm focused on the U.S. medical cannabis sector, offering retail solutions, cultivation support products, and automated dispensing technology like ZaZZZ vending machines. The company collaborates with licensed dispensaries, providing a comprehensive ecosystem for cannabis operations, alongside its e-commerce platform for hemp-derived products.
What Is the Investment Thesis for ERBB?
American Green, Inc. presents an investment profile centered on its diverse offerings within the expanding U.S. medical cannabis industry. The company's strategic focus on technology solutions, including the ZaZZZ automated vending system and cultivation support products, positions it to capitalize on the increasing legalization and professionalization of cannabis operations. With a reported Profit Margin of 658.8% and a P/E ratio of 0.1, the company demonstrates significant profitability relative to its earnings, although these metrics require careful scrutiny given the OTC market context. The firm's Beta of 0.42 suggests lower volatility compared to the broader market. Growth catalysts include the continued expansion of the legal cannabis market, the potential for wider adoption of its ZaZZZ vending technology, and the development of its Access Control Identification and Verification Vending Platform through its collaboration with Endexx Corporation. However, as an 'OTC Other' tier stock with an 'Unknown' disclosure status, ERBB carries inherent risks related to limited regulatory oversight, transparency, and potential liquidity challenges, necessitating thorough due diligence from investors.
Based on FMP financials and quantitative analysis
ERBB Key Highlights
- Market capitalization of 444K, reflecting its micro-cap status.
- Price-to-Earnings (P/E) ratio of 0.09, indicating a low valuation relative to earnings.
- Profit Margin of 658.8%, suggesting exceptionally high profitability.
- Gross Margin of 29.1%, demonstrating the company's efficiency in managing production costs.
- Beta of 0.42, indicating lower volatility compared to the overall market.
Who Are ERBB's Competitors?
ERBB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ERBB's Key Strengths?
- Diverse product portfolio including ZaZZZ vending machines, cultivation products, and hemp-derived goods.
- Strategic collaboration with Endexx Corporation for technology development.
- High reported Profit Margin of 658.8% indicates strong profitability.
- Established presence and brand in the U.S. medical cannabis sector.
What Are ERBB's Weaknesses?
- Micro-cap market capitalization of 444K, indicating small scale.
- Operating on the OTC Other tier with 'Unknown' disclosure status, limiting transparency.
- Reliance on the evolving and complex regulatory landscape of the cannabis industry.
- Beta of 0.42, while low, may not fully reflect inherent risks of an OTC cannabis stock.
What Could Drive ERBB Stock Higher?
- Potential for new state-level medical or recreational cannabis legalizations, expanding American Green's target market for its ZaZZZ vending machines and cultivation products.
- Continued development and potential commercialization of the Access Control Identification and Verification Vending Platform in collaboration with Endexx Corporation.
- Introduction of new cultivation support products or enhancements to existing lines like 'truth lighting' or 'OG tea nutrients' to meet evolving grower demands.
- Expansion of the e-commerce platform for hemp-derived creams and lip balms, potentially through new product launches or increased marketing efforts.
- Strategic partnerships or agreements with additional licensed dispensaries for the deployment of American Green-branded solutions and ZaZZZ units.
What Are the Key Risks for ERBB?
- Negative return on equity (-63.7%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Adverse changes in federal or state cannabis regulations could impact the legality and market for American Green's products and services.
- Intense competition within the rapidly evolving cannabis technology and product sectors from both established and new market entrants.
- Risks associated with operating on the OTC Other tier, including limited liquidity, lack of transparency, and potential for price volatility.
- Challenges in securing additional capital for growth and expansion, particularly given the company's OTC status and the capital-intensive nature of technology development.
- Dependence on the success and growth of licensed medical marijuana dispensaries for the adoption and utilization of its retail and cultivation solutions.
What Are the Growth Opportunities for ERBB?
- **Expansion of ZaZZZ Vending Machine Deployment:** The ZaZZZ consumer-operated vending machine, designed for age-verified dispensing of cannabis products, represents a significant growth avenue. As more states legalize medical and recreational cannabis, the demand for secure, automated, and compliant retail solutions is expected to rise. This technology offers dispensaries efficiency, reduced labor costs, and enhanced security. The market for cannabis retail technology is poised for expansion, with automated solutions becoming increasingly relevant in a regulated environment. American Green's ability to scale ZaZZZ deployments across new and existing licensed dispensaries could drive substantial revenue growth over the next 3-5 years.
- **Increased Adoption of Cultivation Support Products:** American Green offers a suite of specialized cultivation products, including 'Jurassic Water,' 'truth lighting' (LED systems), and 'OG tea nutrients.' With the expansion of commercial cannabis cultivation facilities across the U.S., there is a growing demand for advanced, efficient, and high-yield cultivation solutions. These products cater directly to licensed growers seeking to optimize their operations and improve product quality. The market for cannabis cultivation technology and nutrients is projected to grow in tandem with the overall cannabis industry, offering American Green a pathway to increased sales and market penetration over the medium term (2-4 years).
- **Growth in Hemp-Derived Product E-commerce:** The company's e-commerce platform for hemp-derived creams and lip balms taps into the broader wellness and CBD market. This segment benefits from federal legalization of hemp and growing consumer interest in natural health products. The online retail channel provides scalability and direct access to a national customer base, bypassing some of the stricter regulations associated with THC-containing cannabis. Expanding the product line, enhancing marketing efforts, and optimizing the e-commerce experience could significantly boost sales and brand recognition in the rapidly growing hemp-derived product market over the next 1-3 years.
- **Development and Commercialization of Access Control Identification and Verification Vending Platform:** American Green's collaborative agreement with Endexx Corporation to jointly develop the Access Control Identification and Verification Vending Platform presents a strategic growth opportunity. This platform aims to enhance security and compliance in cannabis dispensing, addressing critical industry needs. Successful development and commercialization of this technology could establish American Green as a leader in secure cannabis retail infrastructure, potentially licensing the technology or integrating it into its existing ZaZZZ machines. This initiative could open new revenue streams and strengthen its market position within the next 3-5 years.
- **Leveraging U.S. Medical Cannabis Market Expansion:** The overarching trend of increasing medical cannabis legalization and market growth across various U.S. states provides a fundamental tailwind for American Green. As more states establish regulated medical cannabis programs, the demand for the company's integrated solutions—from retail technology to cultivation support—will naturally expand. American Green's strategy of collaborating with licensed dispensaries allows it to grow alongside the market without directly engaging in cultivation or dispensing, mitigating some regulatory complexities. This broad market expansion is expected to continue for the foreseeable future, offering sustained growth opportunities over the long term.
What Opportunities Does ERBB Have?
- Continued expansion and legalization of the U.S. medical and recreational cannabis markets.
- Increased demand for automated, compliant retail solutions like ZaZZZ vending machines.
- Growth in the market for specialized cannabis cultivation technologies and nutrients.
- Expansion of the hemp-derived product market through e-commerce channels.
What Threats Does ERBB Face?
- Intensified competition from larger, better-funded companies entering the cannabis technology space.
- Adverse changes in cannabis regulations at federal or state levels.
- Challenges related to operating on the OTC market, including liquidity and investor confidence.
- Potential for technological obsolescence or failure to innovate effectively.
What Are ERBB's Competitive Advantages?
- Proprietary ZaZZZ automated cannabis vending machine technology with age verification.
- Established brand presence and collaborative agreements within the U.S. medical cannabis sector.
- Diverse product portfolio spanning retail technology, cultivation support, and consumer goods.
- Strategic partnership with Endexx Corporation for advanced vending platform development.
- Early mover advantage in specific cannabis technology niches.
What Does ERBB Do?
American Green, Inc. operates as a technology firm primarily engaged in the U.S. medical cannabis sector, headquartered in Phoenix, Arizona. The company designs and implements comprehensive solutions that encompass retail operations, branding, and commercial cultivation, typically offered in collaboration with licensed medical marijuana dispensaries operating under the American Green brand. This integrated approach aims to support the infrastructure of the burgeoning medical cannabis market. A cornerstone of its product portfolio is ZaZZZ, a consumer-operated vending machine specifically engineered for the automated and age-verified dispensing of cannabis-based products, addressing the need for secure and compliant distribution. Beyond retail technology, American Green extends its reach into cultivation support, providing a range of specialized products designed to enhance cannabis plant growth. These include 'Jurassic Water' for plant hydration, 'truth lighting,' an advanced LED lighting system optimized for cannabis cultivation, and 'OG tea nutrients,' a specialized fertilizer blend. Furthermore, the company diversifies its revenue streams through the sale of hemp-derived creams and lip balms, which are distributed via its e-commerce platform. American Green maintains a strategic collaborative agreement with Endexx Corporation, focusing on the joint development of the Access Control Identification and Verification Vending Platform, signaling an ongoing commitment to technological innovation in the sector. The company's evolution saw it transition from its previous identity as Tranzbyte Corporation, officially adopting the name American Green, Inc. in May 2014, marking a strategic pivot towards its current focus on the cannabis industry.
What Products and Services Does ERBB Offer?
- Designs and implements comprehensive solutions for U.S. medical cannabis retail operations.
- Provides branding services for licensed medical marijuana dispensaries.
- Offers commercial cultivation solutions and support.
- Develops and deploys ZaZZZ, a consumer-operated, age-verified cannabis vending machine.
- Sells cultivation support products like 'Jurassic Water' for plants.
- Markets 'truth lighting,' an LED lighting system for cannabis cultivation.
- Provides 'OG tea nutrients,' a specialized fertilizer for cannabis plants.
- Sells hemp-derived creams and lip balms through its e-commerce platform.
- Collaborates with Endexx Corporation on an Access Control Identification and Verification Vending Platform.
How Does ERBB Make Money?
- Generates revenue from the sale and deployment of ZaZZZ automated cannabis vending machines.
- Earns income from selling specialized cultivation support products directly to licensed growers.
- Derives revenue from e-commerce sales of hemp-derived consumer products.
- Potentially earns revenue from branding and operational solutions provided to licensed dispensaries.
- Aims to generate revenue from the joint development and commercialization of the Access Control Identification and Verification Vending Platform.
What Industry Does ERBB Operate In?
American Green, Inc. operates within the dynamic U.S. medical cannabis sector, a segment of the broader healthcare industry experiencing significant regulatory and market evolution. The industry is characterized by increasing state-level legalization, driving demand for cultivation, processing, and retail infrastructure. American Green positions itself as a technology and solutions provider, distinct from pure-play cultivators or retailers, by offering specialized vending machines (ZaZZZ), cultivation aids, and operational support. The competitive landscape includes various players ranging from large multi-state operators to specialized technology firms and product manufacturers. American Green's strategy of collaborating with licensed dispensaries and focusing on niche products like automated dispensing and cultivation nutrients aims to carve out a unique position within this rapidly expanding, yet fragmented, market. The overall U.S. legal cannabis market continues to grow, with projections indicating substantial expansion in the coming years, driven by both medical and adult-use legalization trends.
Who Are ERBB's Key Customers?
- Licensed medical marijuana dispensaries seeking retail and operational solutions.
- Commercial cannabis cultivators requiring specialized growing products and technologies.
- Consumers purchasing hemp-derived creams and lip balms via e-commerce.
- Strategic partners like Endexx Corporation for joint technology development.
ROE -64%Key Financial Metrics
Return on equity for American Green, Inc. stands at -63.7%, a gauge of how efficiently it converts shareholder capital into profit. ERBB trades at a trailing price-to-earnings ratio of 0.09, below the Healthcare sector average of ~23x. Its free cash flow yield is -46.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
American Green, Inc. (ERBB) Valuation Context
Valued at 444K, ERBB is classified as a micro-cap stock. Relative to its peer group, ERBB's quantitative score of 39/100 is below the peer average of 66/100.
Company Profile
American Green, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Phoenix, US. The company is led by CEO David George Gwyther. ERBB has traded publicly since 1996.
F-Score 3/9Financial Health
American Green, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ERBB Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Diverse product portfolio including ZaZZZ vending machines, cultivation products, and hemp-derived goods.
- Strategic collaboration with Endexx Corporation for technology development.
- High reported Profit Margin of 658.8% indicates strong profitability.
- Established presence and brand in the U.S. medical cannabis sector.
Bear Case
- Micro-cap market capitalization of 444K, indicating small scale.
- Operating on the OTC Other tier with 'Unknown' disclosure status, limiting transparency.
- Reliance on the evolving and complex regulatory landscape of the cannabis industry.
- Beta of 0.42, while low, may not fully reflect inherent risks of an OTC cannabis stock.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
ERBB Latest News
No recent news available for ERBB.
ERBB Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ERBB.
Price Targets
Wall Street price target analysis for ERBB.
ERBB MoonshotScore
What does this score mean?
The MoonshotScore rates ERBB's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David George Gwyther
Chief Executive Officer
David George Gwyther serves as the Chief Executive Officer of American Green, Inc., overseeing a team of 41 employees. His leadership is central to the company's strategic direction within the U.S. medical cannabis sector. While specific details on his prior career history and educational background are not provided in the available data, his role involves guiding the company's technology development, market expansion initiatives, and operational collaborations, such as the partnership with Endexx Corporation. His experience is presumed to align with the company's focus on technology solutions and market penetration in a highly regulated industry.
Track Record: Under David George Gwyther's leadership, American Green, Inc. has continued its focus on developing and deploying cannabis-related technologies, including the ZaZZZ vending machine. He has overseen the company's strategic collaboration with Endexx Corporation for the Access Control Identification and Verification Vending Platform. His tenure has seen the company maintain its position in the evolving cannabis market, navigating regulatory complexities and expanding its product offerings to include cultivation support and hemp-derived consumer goods.
ERBB OTC Market Information
American Green, Inc. trades on the 'OTC Other' tier, which is the lowest tier of the OTC Markets Group. This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or that do not qualify for the Pink Open Market. Companies in the 'OTC Other' tier typically have limited or no public disclosure, making it challenging for investors to access current financial and operational information. Unlike companies on major exchanges like NYSE or NASDAQ, which have stringent listing standards for financial health, corporate governance, and regular reporting, 'OTC Other' companies face minimal regulatory oversight, increasing investment risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or 'Unknown' public disclosure, making it difficult to assess financial health and operations.
- Significantly lower liquidity and wider bid-ask spreads, leading to challenges in trading shares.
- Minimal regulatory oversight compared to major exchanges, increasing potential for fraud or mismanagement.
- Higher susceptibility to price manipulation due to low trading volume and limited transparency.
- Difficulty in obtaining reliable valuation metrics and analyst coverage due to lack of information.
- Verify any available financial statements directly from the company or regulatory filings, if any.
- Research management's background, track record, and any past regulatory issues.
- Assess the company's business model and competitive landscape through independent research.
- Investigate any legal or regulatory actions against the company or its executives.
- Evaluate the company's communication with shareholders and its commitment to transparency.
- Understand the specific risks associated with the cannabis industry's evolving legal status.
- Consider the potential for dilution from future capital raises given the OTC status.
- Operates with a physical headquarters in Phoenix, US, indicating a tangible presence.
- Maintains a specific business description with identifiable products (ZaZZZ, cultivation aids, hemp products).
- Has a known CEO, David George Gwyther, providing a clear leadership structure.
- Engages in a collaborative agreement with Endexx Corporation, suggesting external validation.
- Employs 41 individuals, indicating a functional operational team.
What Investors Ask About American Green, Inc. (ERBB) — Healthcare
What does American Green, Inc. do?
American Green, Inc. operates as a technology firm primarily focused on the U.S. medical cannabis sector. The company provides a range of solutions including the design and implementation of retail operations, branding services, and commercial cultivation support, often in partnership with licensed medical marijuana dispensaries. A key offering is the ZaZZZ vending machine, which enables automated and age-verified dispensing of cannabis products. Additionally, American Green offers cultivation-specific products such as 'Jurassic Water,' 'truth lighting' (LED systems), and 'OG tea nutrients.' The company also sells hemp-derived creams and lip balms via its e-commerce platform and is involved in a joint development project for an Access Control Identification and Verification Vending Platform with Endexx Corporation.
What revenue streams does American Green, Inc. have in healthcare?
American Green, Inc. generates revenue primarily through several distinct streams within the broader healthcare and cannabis sector. A significant portion comes from its technology solutions, particularly the deployment and potential servicing of the ZaZZZ consumer-operated vending machines for medical cannabis dispensaries. Another stream is derived from the sale of specialized cultivation support products, including 'Jurassic Water,' 'truth lighting' LED systems, and 'OG tea nutrients,' which are utilized by commercial cannabis growers. Furthermore, the company earns revenue from its e-commerce platform through the sale of hemp-derived creams and lip balms, catering to the wellness market. The collaborative agreement with Endexx Corporation for the Access Control Identification and Verification Vending Platform also represents a potential future revenue stream through licensing or integration.
What are the main risks for ERBB?
Investing in American Green, Inc. (ERBB) carries several notable risks. A primary concern is its status as an 'OTC Other' tier stock with an 'Unknown' disclosure level, which means limited public financial and operational information, making comprehensive due diligence challenging. This also contributes to lower liquidity and wider bid-ask spreads, impacting trading efficiency. The company operates within the U.S. cannabis industry, which is subject to evolving and often unpredictable federal and state regulations; adverse changes could significantly impact its business. Competition is intense, with numerous players vying for market share in cannabis technology, cultivation, and retail. Additionally, the success of its proprietary technologies like ZaZZZ and its cultivation products depends heavily on market adoption and the growth of licensed dispensaries, which can be influenced by external factors.
What are the key factors to evaluate for ERBB?
American Green, Inc. (ERBB) holds an AI score of 39/100 (low). P/E: 0.1x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does ERBB data refresh on this page?
ERBB prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ERBB's recent stock price performance?
American Green, Inc. (ERBB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio including ZaZZZ vending machines, cultivation products, and hemp-derived goods. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ERBB overvalued or undervalued right now?
American Green, Inc. (ERBB) trades at 0.1x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ERBB?
Before investing in American Green, Inc. (ERBB), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived strictly from the provided source data.
- The exceptionally high Profit Margin (658.8%) and low P/E (0.09) are presented as stated in the source data without further interpretation or speculation on their underlying causes, as per content rules.
- The 'Unknown' disclosure status for OTC analysis is directly from the source.
- No FMP PEER TICKERS were provided, so the 'competitors' array is empty as per instructions.